Alivus Life Sciences

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue515.41652.30659.64610.84602.70
Expenses387.95467.16468.34447.85428.57
EBITDA142.89200.77208.52181.29193.90
EBIT127.80185.61192.55164.23175.46
Profit Before Tax127.46185.15191.29162.99174.14
Net Profit95.32136.96141.87121.54130.03
Financial Ratios
Operating Profit Margin28.19%31.28%32.10%30.12%32.98%
Net Profit Margin18.81%21.34%21.84%20.19%22.11%
Earning Per Share (Diluted)7.7511.1411.559.8810.60
Dividends Per Share0.000.000.000.000.00